{"success":true,"data":{"pressRelease":{"id":"107323","rtpr_id":"nPn5tY9PYa","ticker":"DD","exchange":"NYSE","all_tickers":["DD"],"title":"DuPont Reports Second Quarter 2026 Results","author":"PR Newswire","published_at":"2026-08-04T10:00:03.232Z","article_body":"DuPont Reports Second Quarter 2026 Results\n\nPR Newswire\n\nWILMINGTON, Del., Aug. 4, 2026\n\nExceeds Second Quarter 2026 Guidance\n\nRaises Full Year 2026 Guidance\n\nSecond Quarter 2026 Highlights\n\n * Net Sales of $1.8 billion increased 4%; organic sales increased 4% versus\nyear-ago period\n * GAAP Income from continuing operations of $191 million; operating EBITDA of\n$448 million\n * GAAP EPS from continuing operations of $1.37; adjusted EPS of $1.88\n * Cash provided by operating activities from continuing operations of $400\nmillion; transaction-adjusted free cash flow of $326 million representing 127%\nconversion\n * Announces intent to repurchase $250 million of shares in the third quarter\n * Announces the Company's Global Industry Classification Standard (GICS) code\nhas changed to Industrials effective July 31, 2026\nWILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its\nfinancial results((1)) for the second quarter ended June 30, 2026 and raised\nfinancial guidance for the full year 2026.\n\n\"We delivered another strong quarter, exceeding our financial guidance and\ndemonstrating our focus on consistent execution\" said Lori Koch, DuPont Chief\nExecutive Officer. \"Mid-single digit organic growth, strong margin expansion,\ncoupled with robust adjusted EPS growth and free cash flow generation\nunderscore the strength of our market-leading businesses and reflect\ndisciplined execution of our strategic priorities, supported by our ongoing\nfocus on excellence and productivity.\"\n\n\"We are delivering on our commitments, creating value for all of our key\nstakeholders and further strengthening the foundation for sustainable,\nlong-term profitable growth,\" Koch concluded.\n Second Quarter 2026 Consolidated Results((1))\n\n Dollars in millions, except EPS                       2Q'26    2Q'25    Change      Organic Sales ((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                                             $1,819   $1,749   4 %         4 %\n GAAP Income from continuing operations                $191     $24      n.m.\n Operating EBITDA((2))                                 $448     $423     6 %\n Operating EBITDA margin((2)) %                        24.6 %   24.2 %   40 bps\n GAAP EPS from continuing operations                   $1.37    $0.17    n.m.\n Adjusted EPS((2))                                     $1.88    $1.27    48 %\n Cash provided by operating activities – cont. ops.    $400     $74      n.m.\n Transaction-adjusted free cash flow((2))              $326     $107     205 %\n\nNet sales\n\n * Net sales were up 4% on a 4% increase in organic sales.\n * 4% organic sales growth in Healthcare & Water Technologies; 3% organic\nsales growth in Diversified Industrials.\nGAAP Income from continuing operations\n\n * GAAP Income/GAAP EPS from continuing operations improved on higher segment\nearnings and lower interest expense and transaction costs.\nOperating EBITDA\n\n * Operating EBITDA increased on organic growth and productivity.\nAdjusted EPS\n\n * Adjusted EPS increased on higher segment earnings, lower net interest expense\nand a lower tax rate.\nCash provided by operating activities from continuing operations\n\n * Cash provided by operating activities from continuing operations in the\nquarter of $400 million, capital expenditures of $76 million and\nseparation-related transaction costs and other payments of $2 million resulted\nin transaction-adjusted free cash flow and related conversion of $326 million\nand 127%, respectively. (1)  Results and cash flows are presented on a continuing operations basis. See\n      page 6 for further information, including the basis of presentation included\n      in this release.\n (2)  Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS,\n      transaction-adjusted free cash flow and transaction-adjusted free cash flow\n      conversion are non-GAAP measures and only reflect continuing operations. See\n      page 6 for further discussion, including a definition of significant items.\n      Reconciliation to the most directly comparable GAAP measure, including details\n      of significant items begins on page 13 of this communication.\n\n \n Second Quarter 2026 Segment Highlights\n\n Healthcare & Water Technologies\n Dollars in millions        2Q'26    2Q'25    Change      Organic Sales((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                  $856     $817     5 %         4 %\n Operating EBITDA           $258     $248     4 %\n Operating EBITDA margin %  30.1 %   30.4 %   (30) bps\n\nNet sales\n\n * Net sales increased 5% on organic sales growth of 4% and a currency benefit of\n1%.\n* Healthcare Technologies sales up mid-single digits on an organic basis on\nbroad-based growth led by personal protection and biopharma.\n * Water Technologies sales up low-single digits on an organic basis on continued\nstrength in industrial water and semiconductor markets, partially offset by\nweakness in the Middle East.\nOperating EBITDA\n\n * Operating EBITDA increased on organic growth and productivity, partially\noffset by growth investments.\n * Operating EBITDA margin of 30.1% decreased 30 basis points as organic growth\nand productivity were more than offset by less favorable mix and growth\ninvestments. Diversified Industrials\n\n Dollars in millions        2Q'26    2Q'25    Change      Organic Sales((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                  $963     $932     3 %         3 %\n Operating EBITDA           $213     $199     7 %\n Operating EBITDA margin %  22.1 %   21.4 %   70 bps\n\nNet sales\n\n * Net sales increased 3% on organic sales growth in the quarter.\n* Building Technologies sales up low-single digits on an organic basis due to\ngrowth in residential and non-residential construction markets.\n * Industrial Technologies sales up mid-single digits on an organic basis on\ncontinued strength in aerospace coupled with growth in electric vehicle\napplications.\nOperating EBITDA\n\n * Operating EBITDA and margin increased on organic growth, favorable mix and\nproductivity. 2026 Financial Outlook\n\n Dollars in millions, except EPS          2H'26E           Full Year 2026E\n Net sales                                $3,660 - $3,690  $7,160 - $7,190\n Operating EBITDA((2))                    $890 - $910      $1,750 - $1,770\n Adjusted EPS((2))                        $3.65 - $3.80    $7.17 - $7.32\n\n\"Our strong execution and market-driven growth continue to translate into\nhigher earnings and free cash flow generation. As a result of our second\nquarter outperformance, we are again raising the midpoint of our full-year\n2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS\nguidance to $7.24 per share, while increasing our expectation for organic\nsales growth to slightly above 4%,\" said Antonella Franzen, DuPont Chief\nFinancial Officer.\n\n\"With continued strength across healthcare, industrial water, and aerospace\nend-markets, we expect mid-single digit organic sales growth in the second\nhalf and remain focused on driving profitable growth and value creation for\nshareholders.\" Franzen concluded.\n\nConference Call\n\nThe Company will host a live webcast\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=721325396&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=live+webcast)\n of its quarterly earnings conference call with investors to discuss its\nresults and business outlook beginning today at 8:00 a.m. ET. The slide\npresentation that accompanies the conference call will be posted on the\nDuPont's Investor Relations Events and Presentations page\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=296431939&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=page)\n. A replay of the webcast also will be available on the DuPont's Investor\nRelations Events and Presentations page\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=296431939&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=page)\n following the live event.\n\nAbout DuPont\n\nDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions\nthat help transform industries and improve everyday life across our key\nmarkets of healthcare, water, construction, and industrial. More information\nabout the company, its businesses and solutions can be found at www.dupont.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=413172020&u=https%3A%2F%2Fwww.dupont.com%2F&a=www.dupont.com)\n. Investors can access information included on the Investor Relations section\nof the website at investors.dupont.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=3064087474&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=investors.dupont.com)\n.\n\nDuPont(TM) and all products, unless otherwise noted, denoted with (TM),\n(SM) or ® are trademarks, service marks or registered trademarks of\naffiliates of DuPont de Nemours, Inc.\n\nOverview\n\nOn May 26, 2026, DuPont's Board of Directors announced a reverse stock split\nof the Company's common stock, par value $0.01 per share, at a ratio of\n1-for-3, as well as a reduction in the number of authorized shares of its\ncommon stock by a corresponding ratio (the \"Reverse Stock Split\"), as approved\nby shareholders. The Reverse Stock Split became effective on June 24, 2026.\nAll share and share-related information presented in these interim\nConsolidated Financial Statements has been retroactively adjusted in all\nperiods presented to reflect the decreased number of shares resulting from the\nReverse Stock Split and related impacts.\n\nOn April 1, 2026, DuPont completed the sale of the Aramids business (the\n\"Aramids Business\" and the divestiture of the Aramids Business, the \"Aramids\nDivestiture\") to Arclin, a portfolio company of an affiliate of TJC LP for\npre-tax cash proceeds of approximately $1.2 billion, subject to customary\ntransaction adjustments, a note receivable in the principal amount of $300\nmillion (the \"Aramids Note Receivable\") and a non-controlling common equity\ninterest (the \"Aramids Equity Consideration\"), valued at $325 million, in New\nArclin U.S. Holding Corp., which now owns the Arclin global materials business\nand the Aramids Business. The financial results of the divested Aramids\nBusiness are reflected in DuPont's interim Consolidated Financial Statements\nas discontinued operations, along with comparative periods.\n\nOn November 1, 2025, DuPont completed the separation of its semiconductor and\ninterconnect solutions businesses (the \"Electronics Business\" and the\nseparation of the Electronics Business, the \"Electronics Separation\") into an\nindependent public company, Qnity Electronics, Inc. (\"Qnity\"), by way of the\ndistribution to DuPont's stockholders of record as of October 22, 2025 of all\nthe issued and outstanding common stock of Qnity on November 1, 2025 (the\n\"Qnity Distribution\"). As a result, the financial results of the divested\nElectronics Business are reflected in DuPont's interim Consolidated Financial\nStatements as discontinued operations for all periods.\n\nCautionary Statement Regarding Forward-looking Statements\n\nCertain statements in this release may be considered forward-looking\nstatements, within the meaning of the federal securities laws, including\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended (the \"Exchange Act\").\nForward-looking statements often contain words such as \"expect\", \"anticipate\",\n\"intend\", \"plan\", \"believe\", \"seek\", \"see\", \"will\", \"would\", \"target\",\n\"outlook\", \"stabilization\", \"confident\", \"preliminary\", \"initial\", \"continue\",\n\"may\", \"could\", \"project\", \"estimate\", \"forecast\" and similar expressions and\nvariations or negatives of these words. All statements, other than statements\nof historical fact, are forward-looking statements. Forward-looking statements\naddress matters that are, to varying degrees, uncertain and subject to risks,\nuncertainties, and assumptions, many of which are beyond DuPont's control,\nthat could cause actual results to differ materially from those expressed in\nany forward-looking statements.\n\nForward-looking statements are not guarantees of future results. Some of the\nimportant factors that could cause DuPont's actual results to differ\nmaterially from those projected in any such forward-looking statements\ninclude, but are not limited to (i) the ability to realize the intended\nbenefits of the Electronics Separation and the Qnity Distribution, including\nachievement of the intended tax treatment, contractual allocation to, and\nassumption by Qnity of certain liabilities, including certain legacy\nliabilities with respect to per- and polyfluoroalkyl substances (\"PFAS\") and\nthe possibility of disputes, litigation or unanticipated costs in connection\nwith the Electronics Separation and Qnity Distribution; (ii) the impact of the\nAramids Divestiture on DuPont's balance sheet, financial condition and future\nresults of operations; (iii) risks and costs related to the impact of the\narrangement to share future eligible PFAS costs by and among DuPont, Corteva,\nInc. and The Chemours Company, including the outcome of pending or future\nlitigation related to PFAS or PFOA, which includes personal injury claims and\nnatural resource damages claims; the extent and cost of ongoing and potential\nfuture remediation obligations; and changes in laws and regulations applicable\nto PFAS chemicals; (iv) the failure to realize expected benefits and\neffectively manage and achieve anticipated synergies and operational\nefficiencies in connection with the Electronics Separation, the Aramids\nDivestiture and completed and future, if any, divestitures, mergers,\nacquisitions, and other portfolio management, productivity and infrastructure\nactions; (v) risks and uncertainties that are outside the Company's control\nbut adversely impact the overall environment in which DuPont, its customers\nand/or its suppliers operate, including changes in economic, political,\nregulatory, international trade, geopolitical, military conflicts, capital\nmarkets and other external conditions, including pandemics and responsive\nactions, as well as natural and other disasters or weather-related events;\n(vi) the ability to offset increases in cost of inputs, including raw\nmaterials, energy and logistics; (vii) the risks and uncertainties associated\nwith continuing or expanding geopolitical conflicts or trade disputes or\nrestrictions and responsive actions, new or increased tariffs or export\ncontrols, including on exports to China of U.S.-regulated products and\ntechnology; (viii) other risks to DuPont's business and operations, including\nthe risk of impairment; (ix) risks and uncertainties in connection with\ncompleting the $2 billion share buyback announced on November 6, 2025,\nincluding timeline, associated costs and the possibility that the\nauthorization may be suspended or discontinued prior to completion; (x) the\nability to realize the intended benefits of the Reverse Stock Split; (xi) the\nimpact of the invalidation of certain tariffs imposed under the International\nEmergency Economic Powers Act and (xii) other risk factors discussed in\nDuPont's most recent annual report on Form 10-K, and subsequent quarterly\nreports on Form 10-Q and current reports on Form 8-K filed with the U.S.\nSecurities and Exchange Commission.\n\nUnlisted factors may present significant additional obstacles to the\nrealization of forward-looking statements. Consequences of material\ndifferences in results as compared with those anticipated in the\nforward-looking statements could include, among other things, business or\nsupply chain disruption, operational problems, financial loss, legal liability\nto third parties and similar risks, any of which could have a material adverse\neffect on DuPont's consolidated financial condition, results of operations,\ncredit rating or liquidity. Undue reliance should not be placed on\nforward-looking statements, which speak only as of the date they are made.\nDuPont assumes no obligation to publicly provide revisions or updates to any\nforward-looking statements whether as a result of new information, future\ndevelopments or otherwise, should circumstances change, except as otherwise\nrequired by securities and other applicable laws.\n\nNon-GAAP Financial Measures\n\nUnless otherwise indicated, all financial metrics presented reflect continuing\noperations only.\n\nThis communication includes information that does not conform to accounting\nprinciples generally accepted in the United States of America (\"U.S. GAAP\")\nand are considered non-GAAP measures. Management uses these measures\ninternally for planning, forecasting and evaluating the performance of the\nCompany, including allocating resources. DuPont's management believes these\nnon-GAAP financial measures are useful to investors because they provide\nadditional information related to the ongoing performance of DuPont to offer a\nmore meaningful comparison related to future results of operations. These\nnon-GAAP financial measures supplement disclosures prepared in accordance with\nU.S. GAAP, and should not be viewed as an alternative to U.S. GAAP.\nFurthermore, such non-GAAP measures may not be consistent with similar\nmeasures provided or used by other companies. Reconciliations for these\nNon-GAAP measures to U.S. GAAP are provided in the Selected Financial\nInformation and Non-GAAP Measures starting on page 12. Non-GAAP measures\nincluded in this communication are defined below. The Company has not provided\nforward-looking U.S. GAAP financial measures or a reconciliation of\nforward-looking non-GAAP financial measures to the most comparable U.S. GAAP\nfinancial measures on a forward-looking basis because the Company is unable to\npredict with reasonable certainty the ultimate outcome of certain future\nevents. These events include, among others, the impact of portfolio changes,\nincluding asset sales, mergers, acquisitions, and divestitures; contingent\nliabilities related to litigation, environmental and indemnifications matters;\nimpairments and discrete tax items. These items are uncertain, depend on\nvarious factors, and could have a material impact on U.S. GAAP results for the\nguidance period.\n\nKey Terms\n\nSignificant Items\n\nSignificant items are items that arise outside the ordinary course of business\nfor the Company and includes items for nonconsolidated affiliates, that the\nCompany's management believes may cause misinterpretation of underlying\nbusiness and investment performance, both historical and future, based on a\ncombination of some or all of the item's size, unusual nature and infrequent\noccurrence. Management classifies as significant items certain costs and\nexpenses associated with integration and separation activities related to\ntransformational acquisitions and divestitures as they are considered\nunrelated to ongoing business performance. There were no significant items\nassociated with nonconsolidated affiliates recorded for the three and six\nmonth periods ended June 30, 2026 and June 30, 2025.\n\nFuture Reimbursable Indirect Costs\n\nIndirect costs, such as those related to corporate and shared service\nfunctions previously allocated to the separated Electronics Business and\nAramids Business, do not meet the criteria for discontinued operations and are\nreported within continuing operations in all respective periods presented. The\nCompany has, is, will or expects to be reimbursed in accordance with the\napplicable transition service agreements (\"TSAs\") for the portion of indirect\ncosts related to activities the Company is, will or expects to undertake on a\ntransitional basis to support a) Qnity not beyond year end 2027 for services\nand 2040 for site leases and, b) the Aramids Business post the Aramids\nDivestiture, but not beyond 2028 (such indirect costs \"Future Reimbursable\nIndirect Costs\"). Services provided and costs reimbursed in accordance with\nthe applicable TSAs include but are not limited to, costs associated with\ninformation technology services/support, product stewardship and regulatory\nsupport, facilities services, and shared property lease costs.\n\nFuture Reimbursable Indirect Costs do not meet the criteria for discontinued\noperations and therefore are included in both GAAP Net Income from Continuing\nOperations and in GAAP Cash provided by operating activities-continuing\noperations for all periods presented. Future Reimbursable Indirect Costs are\nexcluded from Adjusted Earnings, Operating EBITDA and Transaction-Adjusted\nFree Cash Flow, each defined below. Such indirect costs that are not subject\nto future reimbursement are reported within continuing operations in Corporate\nand are included within Adjusted Earnings, Operating EBITDA, and Cash provided\nby operating activities-continuing operations.\n\nCorporate DDOB Remediation Costs\n\nCorporate DDOB Remediation Costs are environmental remediation costs,\nincluding certain investigate, remediate and restoration costs, associated\nwith discontinued or divested operations, businesses or product lines\n(\"Corporate DDOB Remediation Costs\"). DDOB Remediation Costs are excluded from\nAdjusted Earnings and Operating EBITDA, as defined below, to provide better\ninsight into the underlying business performance of the Company.\n\nNon-GAAP Measure Definitions\n\nOrganic Sales\n\nOrganic Sales is defined as net sales excluding the impacts of currency and\nportfolio.\n\nAdjusted Earnings\n\nAdjusted Earnings is defined as income from continuing operations excluding\nthe after-tax impact of significant items, after-tax impact of amortization\nexpense of intangibles, the after-tax impact of non-operating pension / other\npost employment benefits (\"OPEB\") credits / costs, Future Reimbursable\nIndirect Costs and Corporate DDOB Remediation Costs.\n\nAdjusted Earnings is the numerator used in the calculation of Adjusted EPS, as\nwell as the denominator in Adjusted Free Cash Flow Conversion.\n\nAdjusted EPS\n\nAdjusted EPS is defined as Adjusted Earnings per common share - diluted.\nManagement estimates amortization expense in 2026 associated with intangibles\nto be about $275 million on a pre-tax basis, or approximately $1.54 per share.\n\nOperating EBITDA, EBITDA Margin & Incremental Margin\n\nThe Company's measure of profit/loss for segment reporting purposes is\nOperating EBITDA as this is the manner in which the Company's chief operating\ndecision maker (\"CODM\") assesses performance and allocates resources. The\nCompany defines Operating EBITDA as earnings (i.e., \"Income from continuing\noperations before income taxes\") before interest, depreciation, amortization,\nnon-operating pension / OPEB benefits / charges, and foreign exchange gains /\nlosses, excluding Future Reimbursable Indirect Costs, Corporate DDOB\nRemediation Costs, and adjusted for significant items. Reconciliations of\nthese measures are provided on the following pages.\n\nOperating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.\n\nIncremental Margin is the change in Operating EBITDA divided by the change in\nNet Sales for the applicable period.\n\nAdjusted Free Cash Flow & Adjusted Free Cash Flow Conversion\n\nAdjusted Free Cash Flow is defined as cash provided by/used for operating\nactivities from continuing operations less capital expenditures and excluding\nthe impact of cash inflows/outflows that are unusual in nature and/or\ninfrequent in occurrence that neither relate to the ordinary course of the\nCompany's business nor reflect the Company's underlying business liquidity. As\na result, Adjusted Free Cash Flow represents cash that is available to the\nCompany, after investing in its asset base, to fund obligations using the\nCompany's primary source of liquidity, cash provided by operating activities\nfrom continuing operations. Management believes Adjusted Free Cash Flow, even\nthough it may be defined differently from other companies, is useful to\ninvestors, analysts and others to evaluate the Company's cash flow and\nfinancial performance, and it is an integral measure used in the Company's\nfinancial planning process. Management notes that there were no exclusions for\nitems that are unusual in nature and/or infrequent in occurrence for the three\nand six month periods ended June 30, 2026.\n\nAdjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow\ndivided by Adjusted Earnings. Management uses Adjusted Free Cash Flow\nConversion as an indicator of our ability to convert earnings to cash.\n\nTransaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow\nConversion\n\nManagement believes supplemental non-GAAP financial measures including\nTransaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow\nConversion (each defined below) provide an integral view of information on the\nCompany's underlying business performance during this period of\ntransformational change. Management believes the Electronics Separation and\nAramids Divestiture collectively represent a significant transformational\nchange for the Company and separation-related transaction cost\npayments impact comparability to the Company's continuing operations.\nManagement believes Transaction-Adjusted Free Cash Flow, which may be defined\ndifferently from other companies, is useful to investors, analysts and others\nto evaluate the Company's cash flow and financial performance, and it is an\nintegral measure used in the Company's financial planning process. These\nnon-GAAP financial measures are not intended to represent residual cash flow\nfor discretionary expenditures since other non-discretionary expenditures,\nsuch as mandatory debt service requirements, are not deducted from the\nmeasure.\n\nTransaction-Adjusted Free Cash Flow is defined as cash provided by/used for\noperating activities from continuing operations less capital expenditures and\nremoving the impact of separation-related transaction costs and other payment\nand cash inflows/outflows that are unusual in nature and/or infrequent in\noccurrence that neither relate to the ordinary course of the Company's\nbusiness nor reflect the Company's underlying business liquidity.\n\nTransaction-Adjusted Free Cash Flow Conversion is defined as\nTransaction-Adjusted Free Cash Flow excluding separation-related transaction\ncosts, divided by Adjusted Earnings.\n\nSeparation-related transaction costs and other payments include cash outflows\ndirectly associated with the Electronics Separation and the Aramids\nDivestiture. These costs include advisor and banking fees, payments related to\nestablishing a new capital structure (including fees associated with interest\nrate swaps), capital expenditures required to facilitate physical asset\nseparation, restructuring payments associated with senior leadership, and\nFuture Reimbursable Indirect Costs, among other expenditures.\n\nFuture Reimbursable Indirect Costs are excluded from Adjusted Earnings and\nOperating EBITDA. To provide comparable data analysis, the Company has also\nadjusted payments associated with Future Reimbursable Indirect Costs within\nSeparation-related transaction costs and other payments. This adjustment is\nintended to provide insight into the Company's underlying business\nperformance. For the six months ended June 30, 2026, the Company adjusted $8\nmillion associated with Future Reimbursable Indirect Costs within\nSeparation-related transaction costs and other payments.\n\nAdditionally, $2 and $5 million were reflected in Separation-related\ntransaction costs and other payments for the three and six month periods\nended June 30, 2026, respectively, for capital expenditures incurred to\ncomplete the physical separation of shared locations.\n\nFinally, $6 million of restructuring and short-term incentive program payments\nto former senior leadership were reflected in Separation-related transaction\ncosts and other payments for the six month period ended June 30, 2026. These\npayments were reflected in other cash payments as they related to the\nestablishment of the post-spin leadership structure.\n DuPont de Nemours, Inc.\n\nConsolidated Statements of Operations\n\n                                                                          Three Months Ended                     Six Months Ended\n                                                                          June 30,\nJune 30,\n In millions, except per share amounts (Unaudited)                        2026              2025                 2026              2025\n Net sales                                                                $    1,819        $    1,749           $    3,500        $    3,361\n Cost of sales                                                            1,180             1,143                2,259             2,212\n Research and development expenses                                        42                53                   89                103\n Selling, general and administrative expenses                             269               262                  524               496\n Amortization of intangibles                                              68                74                   136               149\n Restructuring and asset related (benefits) charges - net                 (3)               —                    43                39\n Acquisition, integration and separation costs                            7                 55                   7                 105\n Equity in earnings (loss) of nonconsolidated affiliates                  9                 9                    8                 (6)\n Sundry income (expense) - net                                            42                (9)                  78                91\n Interest expense                                                         41                84                   81                167\n Income from continuing operations before income taxes                    $      266        $        78          $      447        $      175\n Provision for income taxes on continuing operations                      75                54                   106               71\n Income from continuing operations, net of tax                            $      191        $        24          $      341        $      104\n (Loss) income from discontinued operations, net of tax                   (44)              46                   (30)              (615)\n Net income (loss)                                                        $      147        $        70          $      311        $     (511)\n Net income attributable to noncontrolling interests                      4                 11                   7                 19\n Net income (loss) available for DuPont common stockholders               $      143        $        59          $      304        $     (530)\n\n Per common share data:\n Earnings per common share from continuing operations - basic             $     1.38        $     0.17           $     2.45        $     0.73\n (Loss) earnings per common share from discontinued operations - basic    (0.32)            0.25                 (0.22)            (4.53)\n Earnings (loss) per common share - basic                                 $     1.05        $     0.42           $     2.23        $    (3.80)\n Earnings per common share from continuing operations - diluted           $     1.37        $     0.17           $     2.43        $     0.73\n (Loss) earnings per common share from discontinued operations - diluted  (0.32)            0.25                 (0.22)            (4.52)\n Earnings (loss) per common share - diluted                               $     1.05        $     0.42           $     2.22        $    (3.79)\n\n Weighted-average common shares outstanding - basic                       135.9             139.6                136.3             139.6\n Weighted-average common shares outstanding - diluted                     136.8             139.9                137.2             139.9\n\n \n DuPont de Nemours, Inc.\n\nCondensed Consolidated Balance Sheets\n\n In millions, except share amounts (Unaudited)                               June 30, 2026                               December 31, 2025\n Assets\n Current Assets\n Cash and cash equivalents                                                   $                  1,740                    $                    715\n Restricted cash and cash equivalents                                        42                                          42\n Accounts and notes receivable - net                                         1,751                                       1,669\n Inventories                                                                 1,210                                       1,172\n Prepaid and other current assets                                            113                                         121\n Assets of discontinued operations                                           —                                           1,856\n Total current assets                                                        $                  4,856                    $                  5,575\n Property, plant and equipment - net of accumulated depreciation (June 30,   3,379                                       3,464\n 2026 - $3,694; December 31, 2025 - $3,565)\n Other Assets\n Goodwill                                                                    7,840                                       7,915\n Other intangible assets                                                     2,789                                       2,936\n Investments and noncurrent receivables                                      981                                         432\n Deferred income tax assets                                                  221                                         282\n Deferred charges and other assets                                           995                                         971\n Total other assets                                                          $                 12,826                    $                 12,536\n Total Assets                                                                $                 21,061                    $                 21,575\n Liabilities and Equity\n Current Liabilities\n Short-term borrowings                                                       $                        —                  $                       60\n Accounts payable                                                            978                                         995\n Income taxes payable                                                        53                                          54\n Accrued and other current liabilities                                       970                                         882\n Liabilities of discontinued operations                                      —                                           314\n Total current liabilities                                                   $                   2,001                   $                  2,305\n Long-Term Debt                                                              3,125                                       3,134\n Other Noncurrent Liabilities\n Deferred income tax liabilities                                             295                                         405\n Pension and other post-employment benefits - noncurrent                     400                                         432\n Other noncurrent obligations                                                1,359                                       1,196\n Total other noncurrent liabilities                                          $                   2,054                   $                  2,033\n Total Liabilities                                                           $                   7,180                   $                  7,472\n Commitments and contingent liabilities\n Stockholders' Equity\n Common stock (authorized 555,555,556 shares of $0.01 par value each;        1                                           1\n issued 2026: 135,038,855 shares; 2025: 136,398,482 shares)\n Additional paid-in capital                                                  $                 38,710                    38,721\n Accumulated deficit                                                         (24,326)                                    (24,278)\n Accumulated other comprehensive loss                                        (616)                                       (525)\n Total DuPont stockholders' equity                                           $                 13,769                    $                 13,919\n Noncontrolling interests                                                    112                                         184\n Total equity                                                                $                 13,881                    $                 14,103\n Total Liabilities and Equity                                                $                 21,061                    $                 21,575\n\n \n DuPont de Nemours, Inc.\n\nConsolidated Statement of Cash Flows\n\n                                                                                Six Months Ended June 30,\n In millions (Unaudited)                                                        2026                                  2025\n Operating Activities\n Net income (loss)                                                              $                311                  $               (511)\n Loss from discontinued operations                                              (30)                                  (615)\n Net income from continuing operations                                          $                341                  $                104\n Adjustments to reconcile net income to net cash provided by operating\n activities:\n Depreciation and amortization                                                  309                                   326\n Credit for deferred income tax and other tax related items                     45                                    9\n (Earnings) losses of nonconsolidated affiliates (in excess of) less than       (6)                                   7\n dividends received\n Net periodic pension benefit costs                                             6                                     2\n Periodic benefit plan contributions                                            (28)                                  (23)\n Restructuring and asset related charges - net                                  43                                    39\n Interest rate swap gain                                                        —                                     (51)\n Stock based compensation                                                       27                                    22\n Donatelle contingent earn-out true-up                                          (14)                                  (12)\n Other net (income) loss                                                        (2)                                   16\n Changes in assets and liabilities, net of effects of acquired and divested\n companies:\n Accounts and notes receivable                                                  (88)                                  (213)\n Inventories                                                                    (29)                                  (51)\n Accounts payable                                                               92                                    (19)\n Other assets and liabilities, net                                              (64)                                  (5)\n Cash provided by operating activities - continuing operations                  $                632                  $                151\n Investing Activities\n Capital expenditures                                                           (178)                                 (172)\n Proceeds and adjustments to proceeds from sales of businesses, net of cash     1,158                                 —\n divested\n Other investing activities, net                                                9                                     7\n Cash provided by (used for) investing activities - continuing operations       $                989                  $              (165)\n Financing Activities\n Changes in short-term borrowings                                               (60)                                  —\n Purchases of common stock and forward contracts                                (275)                                 —\n Proceeds from issuance of Company stock                                        107                                   4\n Employee taxes paid for share-based payment arrangements                       (22)                                  (22)\n Distributions to noncontrolling interests                                      (11)                                  (5)\n Dividends paid to stockholders                                                 (163)                                 (343)\n Other financing activities, net                                                (1)                                   (7)\n Cash used for financing activities - continuing operations                     $              (425)                  $              (373)\n Cash Flows from Discontinued Operations\n Cash (used for) provided by operations - discontinued operations               (158)                                 540\n Cash used for investing activities - discontinued operations                   (6)                                   (193)\n Cash used for financing activities - discontinued operations                   (3)                                   (17)\n Cash (used for) provided by discontinued operations                            $              (167)                  $                330\n Effect of exchange rate changes on cash, cash equivalents and restricted cash  (7)                                   44\n Increase (decrease) in cash, cash equivalents and restricted cash              $             1,022                   $                (13)\n Cash, cash equivalents and restricted cash from continuing operations,         757                                   1,834\n beginning of period\n Cash, cash equivalents and restricted cash from discontinued operations,       3                                     58\n beginning of period\n Cash, cash equivalents and restricted cash at beginning of period              $                760                  $             1,892\n Cash, cash equivalents and restricted cash from continuing operations, end of  1,782                                 1,817\n period\n Cash, cash equivalents and restricted cash from discontinued operations, end   —                                     62\n of period\n Cash, cash equivalents and restricted cash at end of period                    $             1,782                   $             1,879\n\n \n DuPont de Nemours, Inc.\n\nSelect Segment Information and Non-GAAP Measures\n\n Net Sales by Segment                 Three Months Ended                                  Six Months Ended\n In millions (Unaudited)              Jun 30, 2026              Jun 30, 2025              Jun 30, 2026            Jun 30, 2025\n Healthcare & Water Technologies      $          856            $          817            $        1,662          $        1,580\n Diversified Industrials              963                       932                       1,838                   1,781\n Total                                $        1,819            $        1,749            $        3,500          $        3,361\n\n \n Net Sales Variance by Segment        Three Months Ended June 30, 2026\n                                      Organic Sales                               Currency   Portfolio / Other  Total\n                                      Percent change from prior year (Unaudited)\n Healthcare & Water Technologies      4 %                                         1 %        — %                5 %\n Diversified Industrials              3                                           —          —                  3\n Total                                4 %                                         — %        — %                4 %\n\n \n Net Sales Variance by Segment        Six Months Ended June 30, 2026\n                                      Organic Sales                               Currency  Portfolio / Other  Total\n                                      Percent change from prior year (Unaudited)\n Healthcare & Water Technologies      3 %                                         2 %       — %                5 %\n Diversified Industrials              2                                           1         —                  3\n Total                                3 %                                         1 %       — %                4 %\n\n \n Operating EBITDA by Segment          Three Months Ended                                  Six Months Ended\n In millions (Unaudited)              Jun 30, 2026              Jun 30, 2025              Jun 30, 2026              Jun 30, 2025\n Healthcare & Water Technologies      $          258            $          248            $          502            $          471\n Diversified Industrials              213                       199                       413                       384\n Corporate( 1)                        (23)                      (24)                      (53)                      (72)\n Total                                $          448            $          423            $          862            $          783\n\n 1.  Corporate includes expenses of the Corporate function not allocated to\n     specific business in the Company.\n\n Equity in Earnings (Loss) of Nonconsolidated Affiliates by Segment  Three Months Ended                                          Six Months Ended\n In millions (Unaudited)                                             Jun 30, 2026                  Jun 30, 2025                  Jun 30, 2026                  Jun 30, 2025\n Healthcare & Water Technologies                                     $             1               $            —                $             2               $            —\n Diversified Industrials                                             —                             —                             (1)                           —\n Corporate( 1)                                                       8                             9                             7                             (6)\n Total equity earnings (loss) included in operating EBITDA (GAAP)    $             9               $             9               $             8               $            (6)\n\n 1.  Corporate includes the equity interest acquired in the Delrin® Divestiture\n     transaction.\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n Reconciliation of \"Income from continuing operations, net of tax\" to   Three Months Ended                               Six Months Ended\n \"Operating EBITDA\"\n In millions (Unaudited)                                                Jun 30, 2026            Jun 30, 2025             Jun 30, 2026            Jun 30, 2025\n Income from continuing operations, net of tax (GAAP)                   $         191           $          24            $         341           $         104\n + Provision for income taxes on continuing operations                  75                      54                       106                     71\n Income from continuing operations before income taxes                  $         266           $          78            $         447           $         175\n + Depreciation and amortization                                        154                     166                      309                     326\n  - Interest income (1, 2)                                              24                      18                       34                      35\n  + Interest expense( 3)                                                41                      84                       81                      166\n  - Non-operating pension/OPEB benefit (costs) credits (1)              (1)                     —                        (1)                     2\n  - Foreign exchange gains (losses), net (1)                            4                       (14)                     14                      (17)\n + Future Reimbursable Indirect Costs                                   —                       25                       8                       50\n + Corporate DDOB Remediation Costs                                     6                       2                        10                      5\n - Significant items charge                                             (8)                     (72)                     (54)                    (81)\n Operating EBITDA (non-GAAP)                                            $         448           $         423            $         862           $         783\n\n 1.  Included in \"Sundry income (expense) - net\".\n 2.  The three and six months ended June 30, 2026 and 2025 excludes accrued\n     interest income earned on employee retention credits. Refer to details of\n     significant items on page 14.\n 3.  The six months ended June 30, 2025 excludes interest rate swap basis\n     amortization. Refer to details of significant items on page 14.\n\n Reconciliation of \"Cash provided by operating activities - continuing      Three Months Ended                       Six Months Ended\n operations\" to Adjusted Free Cash Flow (1) , Transaction-Adjusted Free\n Cash Flow(1) and calculation of \"Adjusted Free Cash Flow Conversion\"\n and \"Transaction-Adjusted Free Cash Flow Conversion\"\n In millions (Unaudited)                                                    Jun 30, 2026        Jun 30, 2025         Jun 30, 2026        Jun 30, 2025\n Cash provided by operating activities (GAAP)( 2) - continuing operations   $       400         $        74          $       632         $       151\n Capital expenditures                                                       (76)                (50)                 (178)               (172)\n Adjusted free cash flow (non-GAAP)                                         $       324         $        24          $       454         $       (21)\n Separation-related transaction cost and other payments(3)                  2                   83                   19                  136\n Transaction-adjusted free cash flow (non-GAAP)                             $       326         $       107          $       473         $       115\n\n Adjusted earnings (non-GAAP) (4)                                           $       257         $       177          $       483         $       331\n Adjusted free cash flow conversion (non-GAAP)                              126 %               14 %                 94 %                (6) %\n Transaction-adjusted free cash flow conversion (non-GAAP)                  127 %               60 %                 98 %                35 %\n\n 1  Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated\n    on a continuing operations basis for all periods presented. Refer to the\n    definitions of Non-GAAP metrics on pages 7-8 for additional information.\n 2  Refer to the Consolidated Statement of Cash Flows included in the schedules\n    above for major GAAP cash flow categories as well as further detail relating\n    to the changes in \"Cash provided by operating activities - continuing\n    operations\" for the six month periods noted.\n 3  Other payments for the three months ended June 30, 2026 includes $2 million\n    related of separation-related capital expenditures. Other payments for the six\n    months ended June 30, 2026 includes $5 million of separation-related capital\n    expenditures, $6 million related to restructuring and short-term incentive\n    program payments associated with former senior leadership, and $8 million for\n    Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).\n 4  Refer to page 14 for the Non-GAAP reconciliations of Net income from\n    continuing operations available for DuPont common stockholders to Adjusted\n    Earnings (Non-GAAP).\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n Significant Items Impacting Results for the Three Months Ended June 30, 2026\n In millions, except per share amounts (Unaudited)  Pretax (1)        Net              EPS (3)        Income Statement Classification\n                                                                      Income (2)\n Reported earnings (GAAP)                           $     266         $     187        $    1.37\n Less: Significant items\n Acquisition, integration & separation costs        (7)               (5)              (0.04)         Acquisition, integration and separation costs\n Restructuring and asset related benefits - net     3                 —                —              Restructuring and asset related charges – net\n Other benefits (credits), net (4)                  (4)               (3)              (0.02)         Sundry income (expense) - net; Selling, general and administrative expenses\n Income tax items (5)                               —                 (3)              (0.02)         Provision for income taxes on continuing operations\n Total significant items                            $      (8)        $     (11)       $   (0.08)\n Less: Amortization of intangibles                  (68)              (53)             (0.39)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit costs          (1)               (1)              (0.01)         Sundry income (expense) - net\n Less: Corporate DDOB remediation costs             (6)               (5)              (0.03)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     349         $     257        $    1.88\n\n \n Significant Items Impacting Results for the Three Months Ended June 30, 2025\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $      78        $      24        $    0.17\n Less: Significant items\n Acquisition, integration and separation costs      (55)             (46)             (0.32)         Acquisition, integration and separation costs\n Restructuring and asset related benefits - net     —                1                —              Restructuring and asset related charges - net\n Interest rate swap mark-to-market loss (6)         (27)             (21)             (0.15)         Sundry income (expense) - net\n Other benefits (credits), net (7)                  10               8                0.06           Sundry income (expense) - net\n Income tax items (8)                               —                (18)             (0.13)         Provision for income taxes on continuing operations\n Total significant items                            $     (72)       $     (76)       $   (0.54)\n Less: Amortization of intangibles                  (74)             (58)             (0.42)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit credits        —                —                —              Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (25)             (19)             (0.14)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (2)              —                —              Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     251        $     177        $    1.27\n\n 1.  Income (loss) from continuing operations before income taxes.\n 2.  Net income (loss) from continuing operations available for DuPont common\n     stockholders. The income tax effect on significant items was calculated based\n     upon the enacted tax laws and statutory income tax rates applicable in the tax\n     jurisdiction(s) of the underlying non-GAAP adjustment.\n 3.  Earnings (loss) per common share from continuing operations - diluted.\n 4.  Includes benefits related to an adjustment of the Donatelle contingent\n     earn-out liability ($8 million pre-tax benefit) and legal costs within the\n     Healthcare & Water Technologies segment associated with a pending\n     intellectual property matter ($7 million pre-tax cost), and legal costs\n     associated with personal injury cases associated with Corian® Quartz, a\n     product within the Diversified Industrials segment ($8 million pre-tax cost).\n 5.  Reflects the net impact of a valuation allowance release in Europe and a\n     deferred tax asset reversal in the U.S.\n 6.  The three months ended June 30, 2025 includes non-cash mark-to-market loss\n     related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on\n     the 2022 Swaps.\n 7.  Reflects the accrued interest earned on employee retention credits ($3 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($12 million pre-tax benefit) and legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($5 million pre-tax cost).\n 8.  Reflects the income tax impact of certain internal restructurings related to\n     the Electronics Separation.\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n \n\n Significant Items Impacting Results for the Six Months Ended June 30, 2026\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $     447        $     334        $    2.43\n Less: Significant items\n Acquisition, integration & separation costs        (7)              (5)              (0.04)         Acquisition, integration and separation costs\n Restructuring and asset related charges - net      (43)             (36)             (0.26)         Restructuring and asset related charges - net\n Other benefits (credits), net (4)                  (4)              (3)              (0.02)         Sundry income (expense) - net; Selling, general and administrative expenses\n Income tax items (5)                               —                15               0.11           Provision for income taxes on continuing operations\n Total significant items                            $     (54)       $     (29)       $   (0.21)\n Less: Amortization of intangibles                  (136)            (105)            (0.77)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit costs          (1)              (1)              (0.01)         Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (8)              (6)              (0.04)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (10)             (8)              (0.06)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     656        $     483        $    3.52\n\n \n Significant Items Impacting Results for the Six Months Ended June 30, 2025\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $     175        $     102        $    0.73\n Less: Significant items\n Acquisition, integration and separation costs      (105)            (89)             (0.63)         Acquisition, integration and separation costs\n Restructuring and asset related charges - net      (39)             (32)             (0.23)         Restructuring and asset related charges - net\n Interest rate swap mark-to-market loss (6)         50               39               0.28           Sundry income (expense) - net; Interest expense\n Other benefits (credits), net (7)                  13               11               0.08           Sundry income (expense) - net\n Income tax items (8)                               —                (2)              (0.02)         Provision for income taxes on continuing operations\n Total significant items                            $     (81)       $     (73)       $   (0.52)\n Less: Amortization of intangibles                  (149)            (117)            (0.84)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit credits        2                2                0.01           Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (50)             (39)             (0.28)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (5)              (2)              (0.01)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     458        $     331        $    2.37\n\n 1.  Income (loss) from continuing operations before income taxes.\n 2.  Net income (loss) from continuing operations available for DuPont common\n     stockholders. The income tax effect on significant items was calculated based\n     upon the enacted tax laws and statutory income tax rates applicable in the tax\n     jurisdiction(s) of the underlying non-GAAP adjustment.\n 3.  Earnings (loss) per common share from continuing operations - diluted.\n 4.  Reflects the accrued interest earned on employee retention credits ($3 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($14 million pre-tax benefit), legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($10 million pre-tax cost), and legal\n     costs associated with personal injury cases associated with Corian® Quartz, a\n     product within the Diversified Industrials segment ($11 million pre-tax\n     cost).\n 5.  Reflects the 2026 income tax benefit primarily the result of a discrete tax\n     benefit relating to a change in tax classification of a non-U.S. legal entity\n     ($20 million pre-tax benefit).\n 6.  The six months ended June 30, 2025 includes non-cash mark-to-market gain\n     related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on\n     the 2022 Swaps. The six months ended June 30, 2025 also includes basis\n     amortization on the 2022 Swaps ($1 million pre-tax, reflected in \"Interest\n     expense\" within the Consolidated Statements of Operations).\n 7.  Reflects the accrued interest earned on employee retention credits ($6 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($12 million pre-tax benefit), legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($5 million pre-tax cost).\n 8.  Reflects the income tax impact of certain internal restructurings related to\n     the Electronics Separation.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html\n(https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html)\n\nSOURCE DuPont\n\n\n\nDuPont, Investors: Ann Giancristoforo, ann.giancristoforo@dupont.com; Media: Dan Turner, daniel.a.turner@dupont.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1207185/DuPont-Logo.jpg?id=OA2822301\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn5tY9PYa","title":"DuPont Reports Second Quarter 2026 Results","author":"PR Newswire","ticker":"DD","created":"2026-08-04T10:00:03.232Z","tickers":["DD"],"exchange":"NYSE","article_body":"DuPont Reports Second Quarter 2026 Results\n\nPR Newswire\n\nWILMINGTON, Del., Aug. 4, 2026\n\nExceeds Second Quarter 2026 Guidance\n\nRaises Full Year 2026 Guidance\n\nSecond Quarter 2026 Highlights\n\n * Net Sales of $1.8 billion increased 4%; organic sales increased 4% versus\nyear-ago period\n * GAAP Income from continuing operations of $191 million; operating EBITDA of\n$448 million\n * GAAP EPS from continuing operations of $1.37; adjusted EPS of $1.88\n * Cash provided by operating activities from continuing operations of $400\nmillion; transaction-adjusted free cash flow of $326 million representing 127%\nconversion\n * Announces intent to repurchase $250 million of shares in the third quarter\n * Announces the Company's Global Industry Classification Standard (GICS) code\nhas changed to Industrials effective July 31, 2026\nWILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its\nfinancial results((1)) for the second quarter ended June 30, 2026 and raised\nfinancial guidance for the full year 2026.\n\n\"We delivered another strong quarter, exceeding our financial guidance and\ndemonstrating our focus on consistent execution\" said Lori Koch, DuPont Chief\nExecutive Officer. \"Mid-single digit organic growth, strong margin expansion,\ncoupled with robust adjusted EPS growth and free cash flow generation\nunderscore the strength of our market-leading businesses and reflect\ndisciplined execution of our strategic priorities, supported by our ongoing\nfocus on excellence and productivity.\"\n\n\"We are delivering on our commitments, creating value for all of our key\nstakeholders and further strengthening the foundation for sustainable,\nlong-term profitable growth,\" Koch concluded.\n Second Quarter 2026 Consolidated Results((1))\n\n Dollars in millions, except EPS                       2Q'26    2Q'25    Change      Organic Sales ((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                                             $1,819   $1,749   4 %         4 %\n GAAP Income from continuing operations                $191     $24      n.m.\n Operating EBITDA((2))                                 $448     $423     6 %\n Operating EBITDA margin((2)) %                        24.6 %   24.2 %   40 bps\n GAAP EPS from continuing operations                   $1.37    $0.17    n.m.\n Adjusted EPS((2))                                     $1.88    $1.27    48 %\n Cash provided by operating activities – cont. ops.    $400     $74      n.m.\n Transaction-adjusted free cash flow((2))              $326     $107     205 %\n\nNet sales\n\n * Net sales were up 4% on a 4% increase in organic sales.\n * 4% organic sales growth in Healthcare & Water Technologies; 3% organic\nsales growth in Diversified Industrials.\nGAAP Income from continuing operations\n\n * GAAP Income/GAAP EPS from continuing operations improved on higher segment\nearnings and lower interest expense and transaction costs.\nOperating EBITDA\n\n * Operating EBITDA increased on organic growth and productivity.\nAdjusted EPS\n\n * Adjusted EPS increased on higher segment earnings, lower net interest expense\nand a lower tax rate.\nCash provided by operating activities from continuing operations\n\n * Cash provided by operating activities from continuing operations in the\nquarter of $400 million, capital expenditures of $76 million and\nseparation-related transaction costs and other payments of $2 million resulted\nin transaction-adjusted free cash flow and related conversion of $326 million\nand 127%, respectively. (1)  Results and cash flows are presented on a continuing operations basis. See\n      page 6 for further information, including the basis of presentation included\n      in this release.\n (2)  Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS,\n      transaction-adjusted free cash flow and transaction-adjusted free cash flow\n      conversion are non-GAAP measures and only reflect continuing operations. See\n      page 6 for further discussion, including a definition of significant items.\n      Reconciliation to the most directly comparable GAAP measure, including details\n      of significant items begins on page 13 of this communication.\n\n \n Second Quarter 2026 Segment Highlights\n\n Healthcare & Water Technologies\n Dollars in millions        2Q'26    2Q'25    Change      Organic Sales((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                  $856     $817     5 %         4 %\n Operating EBITDA           $258     $248     4 %\n Operating EBITDA margin %  30.1 %   30.4 %   (30) bps\n\nNet sales\n\n * Net sales increased 5% on organic sales growth of 4% and a currency benefit of\n1%.\n* Healthcare Technologies sales up mid-single digits on an organic basis on\nbroad-based growth led by personal protection and biopharma.\n * Water Technologies sales up low-single digits on an organic basis on continued\nstrength in industrial water and semiconductor markets, partially offset by\nweakness in the Middle East.\nOperating EBITDA\n\n * Operating EBITDA increased on organic growth and productivity, partially\noffset by growth investments.\n * Operating EBITDA margin of 30.1% decreased 30 basis points as organic growth\nand productivity were more than offset by less favorable mix and growth\ninvestments. Diversified Industrials\n\n Dollars in millions        2Q'26    2Q'25    Change      Organic Sales((2))\n\nvs. 2Q'25\nvs. 2Q'25\n Net sales                  $963     $932     3 %         3 %\n Operating EBITDA           $213     $199     7 %\n Operating EBITDA margin %  22.1 %   21.4 %   70 bps\n\nNet sales\n\n * Net sales increased 3% on organic sales growth in the quarter.\n* Building Technologies sales up low-single digits on an organic basis due to\ngrowth in residential and non-residential construction markets.\n * Industrial Technologies sales up mid-single digits on an organic basis on\ncontinued strength in aerospace coupled with growth in electric vehicle\napplications.\nOperating EBITDA\n\n * Operating EBITDA and margin increased on organic growth, favorable mix and\nproductivity. 2026 Financial Outlook\n\n Dollars in millions, except EPS          2H'26E           Full Year 2026E\n Net sales                                $3,660 - $3,690  $7,160 - $7,190\n Operating EBITDA((2))                    $890 - $910      $1,750 - $1,770\n Adjusted EPS((2))                        $3.65 - $3.80    $7.17 - $7.32\n\n\"Our strong execution and market-driven growth continue to translate into\nhigher earnings and free cash flow generation. As a result of our second\nquarter outperformance, we are again raising the midpoint of our full-year\n2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS\nguidance to $7.24 per share, while increasing our expectation for organic\nsales growth to slightly above 4%,\" said Antonella Franzen, DuPont Chief\nFinancial Officer.\n\n\"With continued strength across healthcare, industrial water, and aerospace\nend-markets, we expect mid-single digit organic sales growth in the second\nhalf and remain focused on driving profitable growth and value creation for\nshareholders.\" Franzen concluded.\n\nConference Call\n\nThe Company will host a live webcast\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=721325396&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=live+webcast)\n of its quarterly earnings conference call with investors to discuss its\nresults and business outlook beginning today at 8:00 a.m. ET. The slide\npresentation that accompanies the conference call will be posted on the\nDuPont's Investor Relations Events and Presentations page\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=296431939&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=page)\n. A replay of the webcast also will be available on the DuPont's Investor\nRelations Events and Presentations page\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=296431939&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=page)\n following the live event.\n\nAbout DuPont\n\nDuPont (NYSE: DD) is a global innovation leader, providing advanced solutions\nthat help transform industries and improve everyday life across our key\nmarkets of healthcare, water, construction, and industrial. More information\nabout the company, its businesses and solutions can be found at www.dupont.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=413172020&u=https%3A%2F%2Fwww.dupont.com%2F&a=www.dupont.com)\n. Investors can access information included on the Investor Relations section\nof the website at investors.dupont.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4744559-1&h=3064087474&u=https%3A%2F%2Fwww.investors.dupont.com%2Finvestors%2Fdupont-investors%2Fevents-and-presentations%2Fdefault.aspx&a=investors.dupont.com)\n.\n\nDuPont(TM) and all products, unless otherwise noted, denoted with (TM),\n(SM) or ® are trademarks, service marks or registered trademarks of\naffiliates of DuPont de Nemours, Inc.\n\nOverview\n\nOn May 26, 2026, DuPont's Board of Directors announced a reverse stock split\nof the Company's common stock, par value $0.01 per share, at a ratio of\n1-for-3, as well as a reduction in the number of authorized shares of its\ncommon stock by a corresponding ratio (the \"Reverse Stock Split\"), as approved\nby shareholders. The Reverse Stock Split became effective on June 24, 2026.\nAll share and share-related information presented in these interim\nConsolidated Financial Statements has been retroactively adjusted in all\nperiods presented to reflect the decreased number of shares resulting from the\nReverse Stock Split and related impacts.\n\nOn April 1, 2026, DuPont completed the sale of the Aramids business (the\n\"Aramids Business\" and the divestiture of the Aramids Business, the \"Aramids\nDivestiture\") to Arclin, a portfolio company of an affiliate of TJC LP for\npre-tax cash proceeds of approximately $1.2 billion, subject to customary\ntransaction adjustments, a note receivable in the principal amount of $300\nmillion (the \"Aramids Note Receivable\") and a non-controlling common equity\ninterest (the \"Aramids Equity Consideration\"), valued at $325 million, in New\nArclin U.S. Holding Corp., which now owns the Arclin global materials business\nand the Aramids Business. The financial results of the divested Aramids\nBusiness are reflected in DuPont's interim Consolidated Financial Statements\nas discontinued operations, along with comparative periods.\n\nOn November 1, 2025, DuPont completed the separation of its semiconductor and\ninterconnect solutions businesses (the \"Electronics Business\" and the\nseparation of the Electronics Business, the \"Electronics Separation\") into an\nindependent public company, Qnity Electronics, Inc. (\"Qnity\"), by way of the\ndistribution to DuPont's stockholders of record as of October 22, 2025 of all\nthe issued and outstanding common stock of Qnity on November 1, 2025 (the\n\"Qnity Distribution\"). As a result, the financial results of the divested\nElectronics Business are reflected in DuPont's interim Consolidated Financial\nStatements as discontinued operations for all periods.\n\nCautionary Statement Regarding Forward-looking Statements\n\nCertain statements in this release may be considered forward-looking\nstatements, within the meaning of the federal securities laws, including\nSection 27A of the Securities Act of 1933, as amended, and Section 21E of the\nSecurities Exchange Act of 1934, as amended (the \"Exchange Act\").\nForward-looking statements often contain words such as \"expect\", \"anticipate\",\n\"intend\", \"plan\", \"believe\", \"seek\", \"see\", \"will\", \"would\", \"target\",\n\"outlook\", \"stabilization\", \"confident\", \"preliminary\", \"initial\", \"continue\",\n\"may\", \"could\", \"project\", \"estimate\", \"forecast\" and similar expressions and\nvariations or negatives of these words. All statements, other than statements\nof historical fact, are forward-looking statements. Forward-looking statements\naddress matters that are, to varying degrees, uncertain and subject to risks,\nuncertainties, and assumptions, many of which are beyond DuPont's control,\nthat could cause actual results to differ materially from those expressed in\nany forward-looking statements.\n\nForward-looking statements are not guarantees of future results. Some of the\nimportant factors that could cause DuPont's actual results to differ\nmaterially from those projected in any such forward-looking statements\ninclude, but are not limited to (i) the ability to realize the intended\nbenefits of the Electronics Separation and the Qnity Distribution, including\nachievement of the intended tax treatment, contractual allocation to, and\nassumption by Qnity of certain liabilities, including certain legacy\nliabilities with respect to per- and polyfluoroalkyl substances (\"PFAS\") and\nthe possibility of disputes, litigation or unanticipated costs in connection\nwith the Electronics Separation and Qnity Distribution; (ii) the impact of the\nAramids Divestiture on DuPont's balance sheet, financial condition and future\nresults of operations; (iii) risks and costs related to the impact of the\narrangement to share future eligible PFAS costs by and among DuPont, Corteva,\nInc. and The Chemours Company, including the outcome of pending or future\nlitigation related to PFAS or PFOA, which includes personal injury claims and\nnatural resource damages claims; the extent and cost of ongoing and potential\nfuture remediation obligations; and changes in laws and regulations applicable\nto PFAS chemicals; (iv) the failure to realize expected benefits and\neffectively manage and achieve anticipated synergies and operational\nefficiencies in connection with the Electronics Separation, the Aramids\nDivestiture and completed and future, if any, divestitures, mergers,\nacquisitions, and other portfolio management, productivity and infrastructure\nactions; (v) risks and uncertainties that are outside the Company's control\nbut adversely impact the overall environment in which DuPont, its customers\nand/or its suppliers operate, including changes in economic, political,\nregulatory, international trade, geopolitical, military conflicts, capital\nmarkets and other external conditions, including pandemics and responsive\nactions, as well as natural and other disasters or weather-related events;\n(vi) the ability to offset increases in cost of inputs, including raw\nmaterials, energy and logistics; (vii) the risks and uncertainties associated\nwith continuing or expanding geopolitical conflicts or trade disputes or\nrestrictions and responsive actions, new or increased tariffs or export\ncontrols, including on exports to China of U.S.-regulated products and\ntechnology; (viii) other risks to DuPont's business and operations, including\nthe risk of impairment; (ix) risks and uncertainties in connection with\ncompleting the $2 billion share buyback announced on November 6, 2025,\nincluding timeline, associated costs and the possibility that the\nauthorization may be suspended or discontinued prior to completion; (x) the\nability to realize the intended benefits of the Reverse Stock Split; (xi) the\nimpact of the invalidation of certain tariffs imposed under the International\nEmergency Economic Powers Act and (xii) other risk factors discussed in\nDuPont's most recent annual report on Form 10-K, and subsequent quarterly\nreports on Form 10-Q and current reports on Form 8-K filed with the U.S.\nSecurities and Exchange Commission.\n\nUnlisted factors may present significant additional obstacles to the\nrealization of forward-looking statements. Consequences of material\ndifferences in results as compared with those anticipated in the\nforward-looking statements could include, among other things, business or\nsupply chain disruption, operational problems, financial loss, legal liability\nto third parties and similar risks, any of which could have a material adverse\neffect on DuPont's consolidated financial condition, results of operations,\ncredit rating or liquidity. Undue reliance should not be placed on\nforward-looking statements, which speak only as of the date they are made.\nDuPont assumes no obligation to publicly provide revisions or updates to any\nforward-looking statements whether as a result of new information, future\ndevelopments or otherwise, should circumstances change, except as otherwise\nrequired by securities and other applicable laws.\n\nNon-GAAP Financial Measures\n\nUnless otherwise indicated, all financial metrics presented reflect continuing\noperations only.\n\nThis communication includes information that does not conform to accounting\nprinciples generally accepted in the United States of America (\"U.S. GAAP\")\nand are considered non-GAAP measures. Management uses these measures\ninternally for planning, forecasting and evaluating the performance of the\nCompany, including allocating resources. DuPont's management believes these\nnon-GAAP financial measures are useful to investors because they provide\nadditional information related to the ongoing performance of DuPont to offer a\nmore meaningful comparison related to future results of operations. These\nnon-GAAP financial measures supplement disclosures prepared in accordance with\nU.S. GAAP, and should not be viewed as an alternative to U.S. GAAP.\nFurthermore, such non-GAAP measures may not be consistent with similar\nmeasures provided or used by other companies. Reconciliations for these\nNon-GAAP measures to U.S. GAAP are provided in the Selected Financial\nInformation and Non-GAAP Measures starting on page 12. Non-GAAP measures\nincluded in this communication are defined below. The Company has not provided\nforward-looking U.S. GAAP financial measures or a reconciliation of\nforward-looking non-GAAP financial measures to the most comparable U.S. GAAP\nfinancial measures on a forward-looking basis because the Company is unable to\npredict with reasonable certainty the ultimate outcome of certain future\nevents. These events include, among others, the impact of portfolio changes,\nincluding asset sales, mergers, acquisitions, and divestitures; contingent\nliabilities related to litigation, environmental and indemnifications matters;\nimpairments and discrete tax items. These items are uncertain, depend on\nvarious factors, and could have a material impact on U.S. GAAP results for the\nguidance period.\n\nKey Terms\n\nSignificant Items\n\nSignificant items are items that arise outside the ordinary course of business\nfor the Company and includes items for nonconsolidated affiliates, that the\nCompany's management believes may cause misinterpretation of underlying\nbusiness and investment performance, both historical and future, based on a\ncombination of some or all of the item's size, unusual nature and infrequent\noccurrence. Management classifies as significant items certain costs and\nexpenses associated with integration and separation activities related to\ntransformational acquisitions and divestitures as they are considered\nunrelated to ongoing business performance. There were no significant items\nassociated with nonconsolidated affiliates recorded for the three and six\nmonth periods ended June 30, 2026 and June 30, 2025.\n\nFuture Reimbursable Indirect Costs\n\nIndirect costs, such as those related to corporate and shared service\nfunctions previously allocated to the separated Electronics Business and\nAramids Business, do not meet the criteria for discontinued operations and are\nreported within continuing operations in all respective periods presented. The\nCompany has, is, will or expects to be reimbursed in accordance with the\napplicable transition service agreements (\"TSAs\") for the portion of indirect\ncosts related to activities the Company is, will or expects to undertake on a\ntransitional basis to support a) Qnity not beyond year end 2027 for services\nand 2040 for site leases and, b) the Aramids Business post the Aramids\nDivestiture, but not beyond 2028 (such indirect costs \"Future Reimbursable\nIndirect Costs\"). Services provided and costs reimbursed in accordance with\nthe applicable TSAs include but are not limited to, costs associated with\ninformation technology services/support, product stewardship and regulatory\nsupport, facilities services, and shared property lease costs.\n\nFuture Reimbursable Indirect Costs do not meet the criteria for discontinued\noperations and therefore are included in both GAAP Net Income from Continuing\nOperations and in GAAP Cash provided by operating activities-continuing\noperations for all periods presented. Future Reimbursable Indirect Costs are\nexcluded from Adjusted Earnings, Operating EBITDA and Transaction-Adjusted\nFree Cash Flow, each defined below. Such indirect costs that are not subject\nto future reimbursement are reported within continuing operations in Corporate\nand are included within Adjusted Earnings, Operating EBITDA, and Cash provided\nby operating activities-continuing operations.\n\nCorporate DDOB Remediation Costs\n\nCorporate DDOB Remediation Costs are environmental remediation costs,\nincluding certain investigate, remediate and restoration costs, associated\nwith discontinued or divested operations, businesses or product lines\n(\"Corporate DDOB Remediation Costs\"). DDOB Remediation Costs are excluded from\nAdjusted Earnings and Operating EBITDA, as defined below, to provide better\ninsight into the underlying business performance of the Company.\n\nNon-GAAP Measure Definitions\n\nOrganic Sales\n\nOrganic Sales is defined as net sales excluding the impacts of currency and\nportfolio.\n\nAdjusted Earnings\n\nAdjusted Earnings is defined as income from continuing operations excluding\nthe after-tax impact of significant items, after-tax impact of amortization\nexpense of intangibles, the after-tax impact of non-operating pension / other\npost employment benefits (\"OPEB\") credits / costs, Future Reimbursable\nIndirect Costs and Corporate DDOB Remediation Costs.\n\nAdjusted Earnings is the numerator used in the calculation of Adjusted EPS, as\nwell as the denominator in Adjusted Free Cash Flow Conversion.\n\nAdjusted EPS\n\nAdjusted EPS is defined as Adjusted Earnings per common share - diluted.\nManagement estimates amortization expense in 2026 associated with intangibles\nto be about $275 million on a pre-tax basis, or approximately $1.54 per share.\n\nOperating EBITDA, EBITDA Margin & Incremental Margin\n\nThe Company's measure of profit/loss for segment reporting purposes is\nOperating EBITDA as this is the manner in which the Company's chief operating\ndecision maker (\"CODM\") assesses performance and allocates resources. The\nCompany defines Operating EBITDA as earnings (i.e., \"Income from continuing\noperations before income taxes\") before interest, depreciation, amortization,\nnon-operating pension / OPEB benefits / charges, and foreign exchange gains /\nlosses, excluding Future Reimbursable Indirect Costs, Corporate DDOB\nRemediation Costs, and adjusted for significant items. Reconciliations of\nthese measures are provided on the following pages.\n\nOperating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.\n\nIncremental Margin is the change in Operating EBITDA divided by the change in\nNet Sales for the applicable period.\n\nAdjusted Free Cash Flow & Adjusted Free Cash Flow Conversion\n\nAdjusted Free Cash Flow is defined as cash provided by/used for operating\nactivities from continuing operations less capital expenditures and excluding\nthe impact of cash inflows/outflows that are unusual in nature and/or\ninfrequent in occurrence that neither relate to the ordinary course of the\nCompany's business nor reflect the Company's underlying business liquidity. As\na result, Adjusted Free Cash Flow represents cash that is available to the\nCompany, after investing in its asset base, to fund obligations using the\nCompany's primary source of liquidity, cash provided by operating activities\nfrom continuing operations. Management believes Adjusted Free Cash Flow, even\nthough it may be defined differently from other companies, is useful to\ninvestors, analysts and others to evaluate the Company's cash flow and\nfinancial performance, and it is an integral measure used in the Company's\nfinancial planning process. Management notes that there were no exclusions for\nitems that are unusual in nature and/or infrequent in occurrence for the three\nand six month periods ended June 30, 2026.\n\nAdjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow\ndivided by Adjusted Earnings. Management uses Adjusted Free Cash Flow\nConversion as an indicator of our ability to convert earnings to cash.\n\nTransaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow\nConversion\n\nManagement believes supplemental non-GAAP financial measures including\nTransaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow\nConversion (each defined below) provide an integral view of information on the\nCompany's underlying business performance during this period of\ntransformational change. Management believes the Electronics Separation and\nAramids Divestiture collectively represent a significant transformational\nchange for the Company and separation-related transaction cost\npayments impact comparability to the Company's continuing operations.\nManagement believes Transaction-Adjusted Free Cash Flow, which may be defined\ndifferently from other companies, is useful to investors, analysts and others\nto evaluate the Company's cash flow and financial performance, and it is an\nintegral measure used in the Company's financial planning process. These\nnon-GAAP financial measures are not intended to represent residual cash flow\nfor discretionary expenditures since other non-discretionary expenditures,\nsuch as mandatory debt service requirements, are not deducted from the\nmeasure.\n\nTransaction-Adjusted Free Cash Flow is defined as cash provided by/used for\noperating activities from continuing operations less capital expenditures and\nremoving the impact of separation-related transaction costs and other payment\nand cash inflows/outflows that are unusual in nature and/or infrequent in\noccurrence that neither relate to the ordinary course of the Company's\nbusiness nor reflect the Company's underlying business liquidity.\n\nTransaction-Adjusted Free Cash Flow Conversion is defined as\nTransaction-Adjusted Free Cash Flow excluding separation-related transaction\ncosts, divided by Adjusted Earnings.\n\nSeparation-related transaction costs and other payments include cash outflows\ndirectly associated with the Electronics Separation and the Aramids\nDivestiture. These costs include advisor and banking fees, payments related to\nestablishing a new capital structure (including fees associated with interest\nrate swaps), capital expenditures required to facilitate physical asset\nseparation, restructuring payments associated with senior leadership, and\nFuture Reimbursable Indirect Costs, among other expenditures.\n\nFuture Reimbursable Indirect Costs are excluded from Adjusted Earnings and\nOperating EBITDA. To provide comparable data analysis, the Company has also\nadjusted payments associated with Future Reimbursable Indirect Costs within\nSeparation-related transaction costs and other payments. This adjustment is\nintended to provide insight into the Company's underlying business\nperformance. For the six months ended June 30, 2026, the Company adjusted $8\nmillion associated with Future Reimbursable Indirect Costs within\nSeparation-related transaction costs and other payments.\n\nAdditionally, $2 and $5 million were reflected in Separation-related\ntransaction costs and other payments for the three and six month periods\nended June 30, 2026, respectively, for capital expenditures incurred to\ncomplete the physical separation of shared locations.\n\nFinally, $6 million of restructuring and short-term incentive program payments\nto former senior leadership were reflected in Separation-related transaction\ncosts and other payments for the six month period ended June 30, 2026. These\npayments were reflected in other cash payments as they related to the\nestablishment of the post-spin leadership structure.\n DuPont de Nemours, Inc.\n\nConsolidated Statements of Operations\n\n                                                                          Three Months Ended                     Six Months Ended\n                                                                          June 30,\nJune 30,\n In millions, except per share amounts (Unaudited)                        2026              2025                 2026              2025\n Net sales                                                                $    1,819        $    1,749           $    3,500        $    3,361\n Cost of sales                                                            1,180             1,143                2,259             2,212\n Research and development expenses                                        42                53                   89                103\n Selling, general and administrative expenses                             269               262                  524               496\n Amortization of intangibles                                              68                74                   136               149\n Restructuring and asset related (benefits) charges - net                 (3)               —                    43                39\n Acquisition, integration and separation costs                            7                 55                   7                 105\n Equity in earnings (loss) of nonconsolidated affiliates                  9                 9                    8                 (6)\n Sundry income (expense) - net                                            42                (9)                  78                91\n Interest expense                                                         41                84                   81                167\n Income from continuing operations before income taxes                    $      266        $        78          $      447        $      175\n Provision for income taxes on continuing operations                      75                54                   106               71\n Income from continuing operations, net of tax                            $      191        $        24          $      341        $      104\n (Loss) income from discontinued operations, net of tax                   (44)              46                   (30)              (615)\n Net income (loss)                                                        $      147        $        70          $      311        $     (511)\n Net income attributable to noncontrolling interests                      4                 11                   7                 19\n Net income (loss) available for DuPont common stockholders               $      143        $        59          $      304        $     (530)\n\n Per common share data:\n Earnings per common share from continuing operations - basic             $     1.38        $     0.17           $     2.45        $     0.73\n (Loss) earnings per common share from discontinued operations - basic    (0.32)            0.25                 (0.22)            (4.53)\n Earnings (loss) per common share - basic                                 $     1.05        $     0.42           $     2.23        $    (3.80)\n Earnings per common share from continuing operations - diluted           $     1.37        $     0.17           $     2.43        $     0.73\n (Loss) earnings per common share from discontinued operations - diluted  (0.32)            0.25                 (0.22)            (4.52)\n Earnings (loss) per common share - diluted                               $     1.05        $     0.42           $     2.22        $    (3.79)\n\n Weighted-average common shares outstanding - basic                       135.9             139.6                136.3             139.6\n Weighted-average common shares outstanding - diluted                     136.8             139.9                137.2             139.9\n\n \n DuPont de Nemours, Inc.\n\nCondensed Consolidated Balance Sheets\n\n In millions, except share amounts (Unaudited)                               June 30, 2026                               December 31, 2025\n Assets\n Current Assets\n Cash and cash equivalents                                                   $                  1,740                    $                    715\n Restricted cash and cash equivalents                                        42                                          42\n Accounts and notes receivable - net                                         1,751                                       1,669\n Inventories                                                                 1,210                                       1,172\n Prepaid and other current assets                                            113                                         121\n Assets of discontinued operations                                           —                                           1,856\n Total current assets                                                        $                  4,856                    $                  5,575\n Property, plant and equipment - net of accumulated depreciation (June 30,   3,379                                       3,464\n 2026 - $3,694; December 31, 2025 - $3,565)\n Other Assets\n Goodwill                                                                    7,840                                       7,915\n Other intangible assets                                                     2,789                                       2,936\n Investments and noncurrent receivables                                      981                                         432\n Deferred income tax assets                                                  221                                         282\n Deferred charges and other assets                                           995                                         971\n Total other assets                                                          $                 12,826                    $                 12,536\n Total Assets                                                                $                 21,061                    $                 21,575\n Liabilities and Equity\n Current Liabilities\n Short-term borrowings                                                       $                        —                  $                       60\n Accounts payable                                                            978                                         995\n Income taxes payable                                                        53                                          54\n Accrued and other current liabilities                                       970                                         882\n Liabilities of discontinued operations                                      —                                           314\n Total current liabilities                                                   $                   2,001                   $                  2,305\n Long-Term Debt                                                              3,125                                       3,134\n Other Noncurrent Liabilities\n Deferred income tax liabilities                                             295                                         405\n Pension and other post-employment benefits - noncurrent                     400                                         432\n Other noncurrent obligations                                                1,359                                       1,196\n Total other noncurrent liabilities                                          $                   2,054                   $                  2,033\n Total Liabilities                                                           $                   7,180                   $                  7,472\n Commitments and contingent liabilities\n Stockholders' Equity\n Common stock (authorized 555,555,556 shares of $0.01 par value each;        1                                           1\n issued 2026: 135,038,855 shares; 2025: 136,398,482 shares)\n Additional paid-in capital                                                  $                 38,710                    38,721\n Accumulated deficit                                                         (24,326)                                    (24,278)\n Accumulated other comprehensive loss                                        (616)                                       (525)\n Total DuPont stockholders' equity                                           $                 13,769                    $                 13,919\n Noncontrolling interests                                                    112                                         184\n Total equity                                                                $                 13,881                    $                 14,103\n Total Liabilities and Equity                                                $                 21,061                    $                 21,575\n\n \n DuPont de Nemours, Inc.\n\nConsolidated Statement of Cash Flows\n\n                                                                                Six Months Ended June 30,\n In millions (Unaudited)                                                        2026                                  2025\n Operating Activities\n Net income (loss)                                                              $                311                  $               (511)\n Loss from discontinued operations                                              (30)                                  (615)\n Net income from continuing operations                                          $                341                  $                104\n Adjustments to reconcile net income to net cash provided by operating\n activities:\n Depreciation and amortization                                                  309                                   326\n Credit for deferred income tax and other tax related items                     45                                    9\n (Earnings) losses of nonconsolidated affiliates (in excess of) less than       (6)                                   7\n dividends received\n Net periodic pension benefit costs                                             6                                     2\n Periodic benefit plan contributions                                            (28)                                  (23)\n Restructuring and asset related charges - net                                  43                                    39\n Interest rate swap gain                                                        —                                     (51)\n Stock based compensation                                                       27                                    22\n Donatelle contingent earn-out true-up                                          (14)                                  (12)\n Other net (income) loss                                                        (2)                                   16\n Changes in assets and liabilities, net of effects of acquired and divested\n companies:\n Accounts and notes receivable                                                  (88)                                  (213)\n Inventories                                                                    (29)                                  (51)\n Accounts payable                                                               92                                    (19)\n Other assets and liabilities, net                                              (64)                                  (5)\n Cash provided by operating activities - continuing operations                  $                632                  $                151\n Investing Activities\n Capital expenditures                                                           (178)                                 (172)\n Proceeds and adjustments to proceeds from sales of businesses, net of cash     1,158                                 —\n divested\n Other investing activities, net                                                9                                     7\n Cash provided by (used for) investing activities - continuing operations       $                989                  $              (165)\n Financing Activities\n Changes in short-term borrowings                                               (60)                                  —\n Purchases of common stock and forward contracts                                (275)                                 —\n Proceeds from issuance of Company stock                                        107                                   4\n Employee taxes paid for share-based payment arrangements                       (22)                                  (22)\n Distributions to noncontrolling interests                                      (11)                                  (5)\n Dividends paid to stockholders                                                 (163)                                 (343)\n Other financing activities, net                                                (1)                                   (7)\n Cash used for financing activities - continuing operations                     $              (425)                  $              (373)\n Cash Flows from Discontinued Operations\n Cash (used for) provided by operations - discontinued operations               (158)                                 540\n Cash used for investing activities - discontinued operations                   (6)                                   (193)\n Cash used for financing activities - discontinued operations                   (3)                                   (17)\n Cash (used for) provided by discontinued operations                            $              (167)                  $                330\n Effect of exchange rate changes on cash, cash equivalents and restricted cash  (7)                                   44\n Increase (decrease) in cash, cash equivalents and restricted cash              $             1,022                   $                (13)\n Cash, cash equivalents and restricted cash from continuing operations,         757                                   1,834\n beginning of period\n Cash, cash equivalents and restricted cash from discontinued operations,       3                                     58\n beginning of period\n Cash, cash equivalents and restricted cash at beginning of period              $                760                  $             1,892\n Cash, cash equivalents and restricted cash from continuing operations, end of  1,782                                 1,817\n period\n Cash, cash equivalents and restricted cash from discontinued operations, end   —                                     62\n of period\n Cash, cash equivalents and restricted cash at end of period                    $             1,782                   $             1,879\n\n \n DuPont de Nemours, Inc.\n\nSelect Segment Information and Non-GAAP Measures\n\n Net Sales by Segment                 Three Months Ended                                  Six Months Ended\n In millions (Unaudited)              Jun 30, 2026              Jun 30, 2025              Jun 30, 2026            Jun 30, 2025\n Healthcare & Water Technologies      $          856            $          817            $        1,662          $        1,580\n Diversified Industrials              963                       932                       1,838                   1,781\n Total                                $        1,819            $        1,749            $        3,500          $        3,361\n\n \n Net Sales Variance by Segment        Three Months Ended June 30, 2026\n                                      Organic Sales                               Currency   Portfolio / Other  Total\n                                      Percent change from prior year (Unaudited)\n Healthcare & Water Technologies      4 %                                         1 %        — %                5 %\n Diversified Industrials              3                                           —          —                  3\n Total                                4 %                                         — %        — %                4 %\n\n \n Net Sales Variance by Segment        Six Months Ended June 30, 2026\n                                      Organic Sales                               Currency  Portfolio / Other  Total\n                                      Percent change from prior year (Unaudited)\n Healthcare & Water Technologies      3 %                                         2 %       — %                5 %\n Diversified Industrials              2                                           1         —                  3\n Total                                3 %                                         1 %       — %                4 %\n\n \n Operating EBITDA by Segment          Three Months Ended                                  Six Months Ended\n In millions (Unaudited)              Jun 30, 2026              Jun 30, 2025              Jun 30, 2026              Jun 30, 2025\n Healthcare & Water Technologies      $          258            $          248            $          502            $          471\n Diversified Industrials              213                       199                       413                       384\n Corporate( 1)                        (23)                      (24)                      (53)                      (72)\n Total                                $          448            $          423            $          862            $          783\n\n 1.  Corporate includes expenses of the Corporate function not allocated to\n     specific business in the Company.\n\n Equity in Earnings (Loss) of Nonconsolidated Affiliates by Segment  Three Months Ended                                          Six Months Ended\n In millions (Unaudited)                                             Jun 30, 2026                  Jun 30, 2025                  Jun 30, 2026                  Jun 30, 2025\n Healthcare & Water Technologies                                     $             1               $            —                $             2               $            —\n Diversified Industrials                                             —                             —                             (1)                           —\n Corporate( 1)                                                       8                             9                             7                             (6)\n Total equity earnings (loss) included in operating EBITDA (GAAP)    $             9               $             9               $             8               $            (6)\n\n 1.  Corporate includes the equity interest acquired in the Delrin® Divestiture\n     transaction.\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n Reconciliation of \"Income from continuing operations, net of tax\" to   Three Months Ended                               Six Months Ended\n \"Operating EBITDA\"\n In millions (Unaudited)                                                Jun 30, 2026            Jun 30, 2025             Jun 30, 2026            Jun 30, 2025\n Income from continuing operations, net of tax (GAAP)                   $         191           $          24            $         341           $         104\n + Provision for income taxes on continuing operations                  75                      54                       106                     71\n Income from continuing operations before income taxes                  $         266           $          78            $         447           $         175\n + Depreciation and amortization                                        154                     166                      309                     326\n  - Interest income (1, 2)                                              24                      18                       34                      35\n  + Interest expense( 3)                                                41                      84                       81                      166\n  - Non-operating pension/OPEB benefit (costs) credits (1)              (1)                     —                        (1)                     2\n  - Foreign exchange gains (losses), net (1)                            4                       (14)                     14                      (17)\n + Future Reimbursable Indirect Costs                                   —                       25                       8                       50\n + Corporate DDOB Remediation Costs                                     6                       2                        10                      5\n - Significant items charge                                             (8)                     (72)                     (54)                    (81)\n Operating EBITDA (non-GAAP)                                            $         448           $         423            $         862           $         783\n\n 1.  Included in \"Sundry income (expense) - net\".\n 2.  The three and six months ended June 30, 2026 and 2025 excludes accrued\n     interest income earned on employee retention credits. Refer to details of\n     significant items on page 14.\n 3.  The six months ended June 30, 2025 excludes interest rate swap basis\n     amortization. Refer to details of significant items on page 14.\n\n Reconciliation of \"Cash provided by operating activities - continuing      Three Months Ended                       Six Months Ended\n operations\" to Adjusted Free Cash Flow (1) , Transaction-Adjusted Free\n Cash Flow(1) and calculation of \"Adjusted Free Cash Flow Conversion\"\n and \"Transaction-Adjusted Free Cash Flow Conversion\"\n In millions (Unaudited)                                                    Jun 30, 2026        Jun 30, 2025         Jun 30, 2026        Jun 30, 2025\n Cash provided by operating activities (GAAP)( 2) - continuing operations   $       400         $        74          $       632         $       151\n Capital expenditures                                                       (76)                (50)                 (178)               (172)\n Adjusted free cash flow (non-GAAP)                                         $       324         $        24          $       454         $       (21)\n Separation-related transaction cost and other payments(3)                  2                   83                   19                  136\n Transaction-adjusted free cash flow (non-GAAP)                             $       326         $       107          $       473         $       115\n\n Adjusted earnings (non-GAAP) (4)                                           $       257         $       177          $       483         $       331\n Adjusted free cash flow conversion (non-GAAP)                              126 %               14 %                 94 %                (6) %\n Transaction-adjusted free cash flow conversion (non-GAAP)                  127 %               60 %                 98 %                35 %\n\n 1  Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated\n    on a continuing operations basis for all periods presented. Refer to the\n    definitions of Non-GAAP metrics on pages 7-8 for additional information.\n 2  Refer to the Consolidated Statement of Cash Flows included in the schedules\n    above for major GAAP cash flow categories as well as further detail relating\n    to the changes in \"Cash provided by operating activities - continuing\n    operations\" for the six month periods noted.\n 3  Other payments for the three months ended June 30, 2026 includes $2 million\n    related of separation-related capital expenditures. Other payments for the six\n    months ended June 30, 2026 includes $5 million of separation-related capital\n    expenditures, $6 million related to restructuring and short-term incentive\n    program payments associated with former senior leadership, and $8 million for\n    Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).\n 4  Refer to page 14 for the Non-GAAP reconciliations of Net income from\n    continuing operations available for DuPont common stockholders to Adjusted\n    Earnings (Non-GAAP).\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n Significant Items Impacting Results for the Three Months Ended June 30, 2026\n In millions, except per share amounts (Unaudited)  Pretax (1)        Net              EPS (3)        Income Statement Classification\n                                                                      Income (2)\n Reported earnings (GAAP)                           $     266         $     187        $    1.37\n Less: Significant items\n Acquisition, integration & separation costs        (7)               (5)              (0.04)         Acquisition, integration and separation costs\n Restructuring and asset related benefits - net     3                 —                —              Restructuring and asset related charges – net\n Other benefits (credits), net (4)                  (4)               (3)              (0.02)         Sundry income (expense) - net; Selling, general and administrative expenses\n Income tax items (5)                               —                 (3)              (0.02)         Provision for income taxes on continuing operations\n Total significant items                            $      (8)        $     (11)       $   (0.08)\n Less: Amortization of intangibles                  (68)              (53)             (0.39)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit costs          (1)               (1)              (0.01)         Sundry income (expense) - net\n Less: Corporate DDOB remediation costs             (6)               (5)              (0.03)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     349         $     257        $    1.88\n\n \n Significant Items Impacting Results for the Three Months Ended June 30, 2025\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $      78        $      24        $    0.17\n Less: Significant items\n Acquisition, integration and separation costs      (55)             (46)             (0.32)         Acquisition, integration and separation costs\n Restructuring and asset related benefits - net     —                1                —              Restructuring and asset related charges - net\n Interest rate swap mark-to-market loss (6)         (27)             (21)             (0.15)         Sundry income (expense) - net\n Other benefits (credits), net (7)                  10               8                0.06           Sundry income (expense) - net\n Income tax items (8)                               —                (18)             (0.13)         Provision for income taxes on continuing operations\n Total significant items                            $     (72)       $     (76)       $   (0.54)\n Less: Amortization of intangibles                  (74)             (58)             (0.42)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit credits        —                —                —              Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (25)             (19)             (0.14)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (2)              —                —              Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     251        $     177        $    1.27\n\n 1.  Income (loss) from continuing operations before income taxes.\n 2.  Net income (loss) from continuing operations available for DuPont common\n     stockholders. The income tax effect on significant items was calculated based\n     upon the enacted tax laws and statutory income tax rates applicable in the tax\n     jurisdiction(s) of the underlying non-GAAP adjustment.\n 3.  Earnings (loss) per common share from continuing operations - diluted.\n 4.  Includes benefits related to an adjustment of the Donatelle contingent\n     earn-out liability ($8 million pre-tax benefit) and legal costs within the\n     Healthcare & Water Technologies segment associated with a pending\n     intellectual property matter ($7 million pre-tax cost), and legal costs\n     associated with personal injury cases associated with Corian® Quartz, a\n     product within the Diversified Industrials segment ($8 million pre-tax cost).\n 5.  Reflects the net impact of a valuation allowance release in Europe and a\n     deferred tax asset reversal in the U.S.\n 6.  The three months ended June 30, 2025 includes non-cash mark-to-market loss\n     related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on\n     the 2022 Swaps.\n 7.  Reflects the accrued interest earned on employee retention credits ($3 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($12 million pre-tax benefit) and legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($5 million pre-tax cost).\n 8.  Reflects the income tax impact of certain internal restructurings related to\n     the Electronics Separation.\n\n \n DuPont de Nemours, Inc.\n\nSelected Financial Information and Non-GAAP Measures\n\n \n\n Significant Items Impacting Results for the Six Months Ended June 30, 2026\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $     447        $     334        $    2.43\n Less: Significant items\n Acquisition, integration & separation costs        (7)              (5)              (0.04)         Acquisition, integration and separation costs\n Restructuring and asset related charges - net      (43)             (36)             (0.26)         Restructuring and asset related charges - net\n Other benefits (credits), net (4)                  (4)              (3)              (0.02)         Sundry income (expense) - net; Selling, general and administrative expenses\n Income tax items (5)                               —                15               0.11           Provision for income taxes on continuing operations\n Total significant items                            $     (54)       $     (29)       $   (0.21)\n Less: Amortization of intangibles                  (136)            (105)            (0.77)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit costs          (1)              (1)              (0.01)         Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (8)              (6)              (0.04)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (10)             (8)              (0.06)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     656        $     483        $    3.52\n\n \n Significant Items Impacting Results for the Six Months Ended June 30, 2025\n In millions, except per share amounts (Unaudited)  Pretax (1)       Net              EPS (3)        Income Statement Classification\n                                                                     Income (2)\n Reported earnings (GAAP)                           $     175        $     102        $    0.73\n Less: Significant items\n Acquisition, integration and separation costs      (105)            (89)             (0.63)         Acquisition, integration and separation costs\n Restructuring and asset related charges - net      (39)             (32)             (0.23)         Restructuring and asset related charges - net\n Interest rate swap mark-to-market loss (6)         50               39               0.28           Sundry income (expense) - net; Interest expense\n Other benefits (credits), net (7)                  13               11               0.08           Sundry income (expense) - net\n Income tax items (8)                               —                (2)              (0.02)         Provision for income taxes on continuing operations\n Total significant items                            $     (81)       $     (73)       $   (0.52)\n Less: Amortization of intangibles                  (149)            (117)            (0.84)         Amortization of intangibles\n Less: Non-op pension / OPEB benefit credits        2                2                0.01           Sundry income (expense) - net\n Less: Future reimbursable indirect costs           (50)             (39)             (0.28)         Selling, general and administrative expenses\n Less: Corporate DDOB remediation costs             (5)              (2)              (0.01)         Selling, general and administrative expenses\n Adjusted earnings (non-GAAP)                       $     458        $     331        $    2.37\n\n 1.  Income (loss) from continuing operations before income taxes.\n 2.  Net income (loss) from continuing operations available for DuPont common\n     stockholders. The income tax effect on significant items was calculated based\n     upon the enacted tax laws and statutory income tax rates applicable in the tax\n     jurisdiction(s) of the underlying non-GAAP adjustment.\n 3.  Earnings (loss) per common share from continuing operations - diluted.\n 4.  Reflects the accrued interest earned on employee retention credits ($3 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($14 million pre-tax benefit), legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($10 million pre-tax cost), and legal\n     costs associated with personal injury cases associated with Corian® Quartz, a\n     product within the Diversified Industrials segment ($11 million pre-tax\n     cost).\n 5.  Reflects the 2026 income tax benefit primarily the result of a discrete tax\n     benefit relating to a change in tax classification of a non-U.S. legal entity\n     ($20 million pre-tax benefit).\n 6.  The six months ended June 30, 2025 includes non-cash mark-to-market gain\n     related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on\n     the 2022 Swaps. The six months ended June 30, 2025 also includes basis\n     amortization on the 2022 Swaps ($1 million pre-tax, reflected in \"Interest\n     expense\" within the Consolidated Statements of Operations).\n 7.  Reflects the accrued interest earned on employee retention credits ($6 million\n     pre-tax benefit), benefits related to an adjustment of the Donatelle\n     contingent earn-out liability ($12 million pre-tax benefit), legal costs\n     within the Healthcare & Water Technologies segment associated with a\n     pending intellectual property matter ($5 million pre-tax cost).\n 8.  Reflects the income tax impact of certain internal restructurings related to\n     the Electronics Separation.\n\n \n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html\n(https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html)\n\nSOURCE DuPont\n\n\n\nDuPont, Investors: Ann Giancristoforo, ann.giancristoforo@dupont.com; Media: Dan Turner, daniel.a.turner@dupont.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1207185/DuPont-Logo.jpg?id=OA2822301\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-04T10:00:03.30469183Z","server_sent_at_ms":1785837603304},"received_at":"2026-08-04T10:00:03.554Z","source_url":"https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html"},"analysis":{"id":"96321","press_release_id":"107323","analysis_json":{"industry":{"label":"Industrial Conglomerates","sector":"Industrials"},"redFlags":["Reverse stock split (1-for-3) effective June 24, 2026","Results exclude discontinued operations (Electronics and Aramids)"],"eventType":"earnings","narrative":"DuPont reported Q2 net sales of $1.819 billion, up 4% year-over-year, with operating EBITDA increasing 6% to $448 million.\n\nAdjusted EPS surged 48% to $1.88, driving a raise in full-year 2026 guidance with adjusted EPS now expected between $7.17 and $7.32 per share.\n\nThe company announced a $250 million share repurchase intent for Q3 and confirmed its GICS sector classification changed to Industrials effective July 31.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Strong beat-and-raise with robust FCF conversion and a new buyback authorization."},"keyFigures":{"eps":1.37,"revenue":1819000000,"guidance":"FY26 revenue $7.16B-$7.19B, Op EBITDA $1.75B-$1.77B, Adj EPS $7.17-$7.32","revenueYoy":"4%","customDimensions":{"adj_eps":1.88,"buyback_amount":250000000,"fcf_conversion":"127%","operating_ebitda":448000000,"reverse_split_ratio":"1-for-3","organic_sales_growth":"4%","transaction_adjusted_fcf":326000000}},"quotedText":"We delivered another strong quarter, exceeding our financial guidance and demonstrating our focus on consistent execution","namedEntities":{"people":[{"name":"Lori Koch","role":"Chief Executive Officer"},{"name":"Antonella Franzen","role":"Chief Financial Officer"}],"products":[],"companies":[{"name":"DuPont","ticker":"DD"},{"name":"Qnity Electronics, Inc.","relationship":"divested subsidiary"},{"name":"Arclin","relationship":"acquirer of Aramids business"},{"name":"Corteva, Inc.","relationship":"related party"},{"name":"The Chemours Company","relationship":"related party"}],"dollarAmounts":[{"amount":"$1.819 billion","context":"Q2 2026 net sales"},{"amount":"$448 million","context":"Q2 2026 operating EBITDA"},{"amount":"$1.37","context":"Q2 2026 GAAP EPS"},{"amount":"$1.88","context":"Q2 2026 adjusted EPS"},{"amount":"$326 million","context":"Q2 2026 transaction-adjusted free cash flow"},{"amount":"$250 million","context":"Q3 share repurchase authorization"},{"amount":"$1.2 billion","context":"Aramids business pre-tax cash proceeds"},{"amount":"$300 million","context":"Aramids Note Receivable"},{"amount":"$325 million","context":"Aramids Equity Consideration"}]},"materialImpact":{"score":4,"reasoning":"Company beat guidance and raised full-year outlook. Adjusted EPS grew 48% YoY to $1.88, and transaction-adjusted FCF hit $326M with 127% conversion. Additionally, a $250M buyback was announced."},"tickerRelevance":{"others":[],"primary":"DD"},"globalImportance":45,"audienceRelevance":55,"eventTypeSecondary":["guidance_update","buyback","reverse_split"],"importanceComponents":{"tickerTier":"large-cap","eventGravity":"earnings_beat_and_raise","sectorWeight":"Industrials","householdBrandBoost":true}},"event_type":"earnings","event_type_secondary":["guidance_update","buyback","reverse_split"],"sentiment":"bullish","material_impact_score":4,"narrative":"DuPont reported Q2 net sales of $1.819 billion, up 4% year-over-year, with operating EBITDA increasing 6% to $448 million.\n\nAdjusted EPS surged 48% to $1.88, driving a raise in full-year 2026 guidance with adjusted EPS now expected between $7.17 and $7.32 per share.\n\nThe company announced a $250 million share repurchase intent for Q3 and confirmed its GICS sector classification changed to Industrials effective July 31.","key_figures":{"eps":1.37,"revenue":1819000000,"guidance":"FY26 revenue $7.16B-$7.19B, Op EBITDA $1.75B-$1.77B, Adj EPS $7.17-$7.32","revenueYoy":"4%","customDimensions":{"adj_eps":1.88,"buyback_amount":250000000,"fcf_conversion":"127%","operating_ebitda":448000000,"reverse_split_ratio":"1-for-3","organic_sales_growth":"4%","transaction_adjusted_fcf":326000000}},"named_entities":{"people":[{"name":"Lori Koch","role":"Chief Executive Officer"},{"name":"Antonella Franzen","role":"Chief Financial Officer"}],"products":[],"companies":[{"name":"DuPont","ticker":"DD"},{"name":"Qnity Electronics, Inc.","relationship":"divested subsidiary"},{"name":"Arclin","relationship":"acquirer of Aramids business"},{"name":"Corteva, Inc.","relationship":"related party"},{"name":"The Chemours Company","relationship":"related party"}],"dollarAmounts":[{"amount":"$1.819 billion","context":"Q2 2026 net sales"},{"amount":"$448 million","context":"Q2 2026 operating EBITDA"},{"amount":"$1.37","context":"Q2 2026 GAAP EPS"},{"amount":"$1.88","context":"Q2 2026 adjusted EPS"},{"amount":"$326 million","context":"Q2 2026 transaction-adjusted free cash flow"},{"amount":"$250 million","context":"Q3 share repurchase authorization"},{"amount":"$1.2 billion","context":"Aramids business pre-tax cash proceeds"},{"amount":"$300 million","context":"Aramids Note Receivable"},{"amount":"$325 million","context":"Aramids Equity Consideration"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-04T10:11:19.420Z","global_importance":45,"audience_relevance":55,"importance_components":{"tickerTier":"large-cap","eventGravity":"earnings_beat_and_raise","sectorWeight":"Industrials","householdBrandBoost":true}},"durationMs":157920,"modelName":"glm-4.7"}}